Expert Analysis of Therapy Studies
From our partner: CMEWeb
Clinicians require up-to-date knowledge of evidence-based treatment of initial and recurrent CDI to reduce its burden and improve clinical outcomes.
The target audience for this initiative includes oncologists, oncology APPs and nurses, and other healthcare professionals (HCPs) involved in managing patients with breast cancer..
To address the educational needs of oncologists and multidisciplinary oncology care team practitioners in the treatment of lung cancer.
This webcast will review the advantages and disadvantages of currently available treatment options for opioid-induced constipation (OIC)
This activity presents a robust roundtable discussion in which our expert faculty provides insights on such issues as determining the optimal timing and approach for autologous stem cell transplantation (ASCT), considering new factors when weighing the benefits and risks of maintenance therapy, and choosing between the various therapeutic options in the relapsed/refractory setting. This activity includes downloadable resources (including supplemental figures and tables).
Major Depressive Disorder (MDD) is a debilitating condition that nearly 20% of the general population in the United States will experience at some point in their life. The ultimate goal of care providers is to move patients suffering from MDD to remission, then recovery, and to avoid a relapse. While this alone is a challenge for clinicians, it becomes even more difficult in patients with cardiovascular disease risk factors such as smoking, diabetes, hypertension, obesity and dyslipidemia. Further complicating matters are the risks associated with some medications used to treat depression.
The expansion of clinical options brings both opportunities and challenges for health care providers who see myeloma patients.